Pietro Berico

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 12

Top Venues

Cancers

Proceedings of the National Academy of Sciences of the United States of America

Nature communications

EMBO reports

Institut de Genetique et de Biologie Moleculaire et Cellulaire Biologie et Génomique structurale

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Institut de Genetique et de Biologie Moleculaire et Cellulaire Biologie et Génomique structurale

France

PhD student :: Functional Genomic and Cancer

Publications

Luca Di Leo, Chiara Pagliuca, Ali Kishk, Salvatore Rizza, Christina Tsiavou, Chiara Pecorari, Christina Dahl, Maria Pires Pacheco, Rikke Tholstrup, Jonathan Richard Brewer, Pietro Berico, Eva Hernando, Francesco Cecconi, Robert Ballotti, Corine Bertolotto, Giuseppe Filomeni, Morten Frier Gjerstorff, Thomas Sauter, Penny Lovat, Per Guldberg, Daniela De Zio
AMBRA1 levels predict resistance to MAPK inhibitors in melanoma. Proceedings of the National Academy of Sciences of the United States of America 121 (25) (2024)
Luca Di Leo, Chiara Pagliuca, Ali Kishk, Salvatore Rizza, Christina Tsiavou, Chiara Pecorari, Christina Dahl, Maria Pires Pacheco, Rikke Tholstrup, Jonathan Richard Brewer, Pietro Berico, Eva Hernando, Francesco Cecconi, Robert Ballotti, Corine Bertolotto, Giuseppe Filomeni, Morten Frier Gjerstorff, Thomas Sauter, Penny Lovat, Per Guldberg, Daniela De Zio
AMBRA1 levels predict resistance to MAPK inhibitors in melanoma. Proceedings of the National Academy of Sciences of the United States of America 121 (25) (2024)
Luca Di Leo, Chiara Pagliuca, Ali Kishk, Salvatore Rizza, Christina Tsiavou, Chiara Pecorari, Christina Dahl, Maria Pires Pacheco, Rikke Tholstrup, Jonathan Richard Brewer, Pietro Berico, Eva Hernando, Francesco Cecconi, Robert Ballotti, Corine Bertolotto, Giuseppe Filomeni, Morten Frier Gjerstorff, Thomas Sauter, Penny Lovat, Per Guldberg, Daniela De Zio
AMBRA1 levels predict resistance to MAPK inhibitors in melanoma. Proceedings of the National Academy of Sciences of the United States of America 121 (25) (2024)
Jérémy Sandoz, Max Cigrang, Amélie Zachayus, Philippe Catez, Lise-Marie Donnio, Clèmence Elly, Jadwiga Nieminuszczy, Pietro Berico, Cathy Braun, Sergey Alekseev, Jean-Marc Egly, Wojciech Niedzwiedz, Giuseppina Giglia-Mari, Emmanuel Compe, Frederic Coin
Active mRNA degradation by EXD2 nuclease elicits recovery of transcription after genotoxic stress. Nature communications 14 (1) (2023)
Jérémy Sandoz, Max Cigrang, Amélie Zachayus, Philippe Catez, Lise-Marie Donnio, Clèmence Elly, Jadwiga Nieminuszczy, Pietro Berico, Cathy Braun, Sergey Alekseev, Jean-Marc Egly, Wojciech Niedzwiedz, Giuseppina Giglia-Mari, Emmanuel Compe, Frederic Coin
Active mRNA degradation by EXD2 nuclease elicits recovery of transcription after genotoxic stress. Nature communications 14 (1) (2023)
Jérémy Sandoz, Max Cigrang, Amélie Zachayus, Philippe Catez, Lise-Marie Donnio, Clèmence Elly, Jadwiga Nieminuszczy, Pietro Berico, Cathy Braun, Sergey Alekseev, Jean-Marc Egly, Wojciech Niedzwiedz, Giuseppina Giglia-Mari, Emmanuel Compe, Frederic Coin
Active mRNA degradation by EXD2 nuclease elicits recovery of transcription after genotoxic stress. Nature communications 14 (1) (2023)
Andrey Rubanov, Pietro Berico, Eva Hernando
Epigenetic Mechanisms Underlying Melanoma Resistance to Immune and Targeted Therapies. Cancers 14 (23) (2022)
Andrey Rubanov, Pietro Berico, Eva Hernando
Epigenetic Mechanisms Underlying Melanoma Resistance to Immune and Targeted Therapies. Cancers 14 (23) (2022)
Andrey Rubanov, Pietro Berico, Eva Hernando
Epigenetic Mechanisms Underlying Melanoma Resistance to Immune and Targeted Therapies. Cancers 14 (23) (2022)
Andrey Rubanov, Pietro Berico, Eva Hernando
Epigenetic Mechanisms Underlying Melanoma Resistance to Immune and Targeted Therapies. Cancers 14 (23) (2022)
Pietro Berico, Max Cigrang, Guillaume Davidson, Cathy Braun, Jeremy Sandoz, Stephanie Legras, Bujamin Hektor Vokshi, Nevena Slovic, François Peyresaubes, Carlos Mario Gene Robles, Jean Marc Egly, Emmanuel Compe, Irwin Davidson, Frederic Coin
CDK7 and MITF repress a transcription program involved in survival and drug tolerance in melanoma. EMBO reports 22 (9) (2021)
Pietro Berico, Frédéric Coin
Is TFIIH the new Achilles heel of cancer cells? Transcription 9 (1) (2017)

Pietro Berico.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Pietro Berico